[1]
“Comparative Assessment of the Metabolic Impact of Risperidone and Trifluoperazine in Drug-Naïve Psychotic Patients: A Prospective Observational Study”, CIJMR, vol. 5, no. 02, pp. 68–73, Aug. 2026, doi: 10.58999/cijmr.v5i02.370.